Yakira Capital Management »

Kinnate Biopharma shares owned by Yakira Capital Management

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Yakira Capital Management from 13F filings

Historical chart of Yakira Capital Management investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Yakira Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Yakira Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 497k 2.66

More positions owned by Yakira Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Pioneer Natural Resources (PXD)
Iac Com New (IAC)
Virtus Global Divid Income F (ZTR)
Seritage Growth Pptys Cl A (SRG)
American Equity Investment Life Holding (AEL)
Capri Holdings SHS (CPRI)
Monterey Cap Acquisition Cor Class A Com (MCAC)
Axonics Modulation Technolog (AXNX)
Broad Capital Acquisition (BRAC)
Sp Plus (SP)
Fortune Rise Acquisition Cor Cl A (FRLA)
Alpha Star Acquisition Corp Ordinary Shares (ALSA)
United States Steel Corporation (X)
Enerplus Corp (ERF)

View all positions for Yakira Capital Management

Top funds holding Kinnate Biopharma

Foresite Capital Management IV
OrbiMed Advisors
Foresite Capital Management V
Lynx1 Capital Management
Viking Global Investors
Susquehanna International
Vanguard Group
Deltec Asset Management
Tang Capital Management
Acadian Asset Management
BML Capital Management
Yakira Capital Management
BlackRock
Group One Trading
GSA Capital Partners

View all funds holding Kinnate Biopharma